Late-breaking results from Eli Lilly and Company (NYSE: LLY) and Incyte (NASDAQ: INCY) found adolescent patients (ages 12 to under 18) with severe alopecia areata (AA) treated with once-daily ...

The third-place slot marked another return to form. Novo Nordisk’s Wegovy reclaimed the seat it held in December, backed by ...

Eli Lilly plans to launch its blockbuster diabetes and weight-loss drug in major emerging markets like India, Brazil and ...

Healthcare & Pharmaceuticalscategory· February 28, 2025 Eli Lilly takes aim at weight-loss drug copies with new ad campaign Eli Lilly launched an ad campaign on Friday, cautioning patients ...

Eli Lilly has stepped ... year in a row that Lilly has used the Oscars as a platform to drive home a message about GLP-1-based obesity therapies, having aired an ad in 2024 that urged people ...

Eli Lilly has since announced plans to invest at least $27 billion to build four new manufacturing plants in the U.S. Pfizer has also said it might move overseas manufacturing to its ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Eli Lilly has said it is seeking permission to build a new biopharmaceutical manufacturing facility in Ireland that will be used to produce active ingredients for its biologic medicines ...

Derived prices are not provided by exchanges. They are derived by market makers in CFD OTC market and hence prices may not be accurate and may differ from the actual market price, meaning prices ...